Free Trial
NASDAQ:LFVN

LifeVantage (LFVN) Stock Price, News & Analysis

LifeVantage logo
$12.91 -0.02 (-0.15%)
(As of 11:45 AM ET)

About LifeVantage Stock (NASDAQ:LFVN)

Key Stats

Today's Range
$12.81
$13.71
50-Day Range
$9.75
$14.44
52-Week Range
$5.22
$15.15
Volume
15,480 shs
Average Volume
62,152 shs
Market Capitalization
$161.63 million
P/E Ratio
40.35
Dividend Yield
1.24%
Price Target
N/A
Consensus Rating
N/A

Company Overview

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. In addition, it offers bath and body, and targeted relief products, such as body lotion, body wash, body butter, deodorant, soothing balm, and body rub under the TrueScience brand name. It sells its products through its website and network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company was founded in 2003 and is headquartered in Lehi, Utah.

LifeVantage Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
59th Percentile Overall Score

LFVN MarketRank™: 

LifeVantage scored higher than 59% of companies evaluated by MarketBeat, and ranked 470th out of 952 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for LifeVantage.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of LifeVantage is 40.35, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 126.99.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of LifeVantage is 40.35, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 93.09.

  • Price to Book Value per Share Ratio

    LifeVantage has a P/B Ratio of 5.84. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about LifeVantage's valuation and earnings.
  • Percentage of Shares Shorted

    2.58% of the float of LifeVantage has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeVantage has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LifeVantage has recently increased by 11.86%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    LifeVantage pays a meaningful dividend of 1.18%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    LifeVantage does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of LifeVantage is 50.00%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about LifeVantage's dividend.
  • Percentage of Shares Shorted

    2.58% of the float of LifeVantage has been sold short.
  • Short Interest Ratio / Days to Cover

    LifeVantage has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in LifeVantage has recently increased by 11.86%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    LifeVantage has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for LifeVantage this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for LFVN on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 1 people have added LifeVantage to their MarketBeat watchlist in the last 30 days. This is a decrease of -86% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, LifeVantage insiders have bought more of their company's stock than they have sold. Specifically, they have bought $8,065.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    20.65% of the stock of LifeVantage is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 35.32% of the stock of LifeVantage is held by institutions.

  • Read more about LifeVantage's insider trading history.
Receive LFVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeVantage and its competitors with MarketBeat's FREE daily newsletter.

LFVN Stock News Headlines

105K Reasons To Be Bullish On Lifevantage Stock
Massive Insider Trade At Lifevantage
Financial Prophecy
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
See More Headlines

LFVN Stock Analysis - Frequently Asked Questions

LifeVantage's stock was trading at $6.00 on January 1st, 2024. Since then, LFVN shares have increased by 115.2% and is now trading at $12.91.
View the best growth stocks for 2024 here
.

LifeVantage Co. (NASDAQ:LFVN) issued its earnings results on Tuesday, October, 29th. The company reported $0.15 EPS for the quarter, hitting analysts' consensus estimates of $0.15. The firm earned $47.21 million during the quarter. LifeVantage had a trailing twelve-month return on equity of 29.24% and a net margin of 2.11%.

Top institutional shareholders of LifeVantage include Capital Management Corp VA (3.31%), Geode Capital Management LLC (0.95%), HighTower Advisors LLC (0.42%) and Barclays PLC (0.34%). Insiders that own company stock include Judd Dayton, Darwin Lewis, Garry Paul Mauro and Michael A Beindorff.
View institutional ownership trends
.

Shares of LFVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeVantage investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Company Calendar

Ex-Dividend for 9/17 Dividend
9/09/2024
Dividend Payable
9/17/2024
Last Earnings
10/29/2024
Today
11/21/2024
Ex-Dividend for 12/16 Dividend
12/02/2024
Dividend Payable
12/16/2024
Next Earnings (Estimated)
2/04/2025
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:LFVN
Employees
260
Year Founded
N/A

Profitability

Net Income
$2.94 million
Pretax Margin
3.11%

Debt

Sales & Book Value

Annual Sales
$200.16 million
Cash Flow
$0.82 per share
Book Value
$2.05 per share

Miscellaneous

Free Float
9,939,000
Market Cap
$161.88 million
Optionable
Optionable
Beta
0.84

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:LFVN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners